ES014

· Elpiscience (Suzhou) Biopharma, Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ES014, covering 2025-07-30 to 2025-08-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ES014 in Patients With Locally Advanced or Metastatic Solid Tumours [Phase 1]